Peptide record

TPDB45911

Antiviral standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45911
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 5-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
DDIWK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C31H45N7O10
ARNCEQGHLMFPSTYV
D
675.74
3.88
1
2
2
-1
3.15
-1.460
78.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: >10 hour
5500
8.14
0
Residue Composition
number
0
A
0
R
0
N
2
D
0
C
0
E
0
Q
0
G
0
H
1
I
0
L
1
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 2 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 0 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
5 reviewed residue count
C31H45N7O10 sequence-only estimate (linear, free termini)
675.74 sequence-only estimate (linear, free termini)
3.88 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
3.15 sequence-only estimate (linear, free termini)
-1.460 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0